Argo Biopharma Doses First Patient in BW-41012 Trial
SHANGHAI, China & NEW YORK, July 20, 2026 Argo Biopharma has announced the successful dosing of the first participant...
IND approval
Advertisement
Antengene Secures China IND Clearance for ATG-201
SHANGHAI and HONG KONG, China, June 10, 2026 Antengene announced that China’s National Medical Products Administration (NMPA) has approved...
FDA Fast-Tracks Psychedelic Therapies for Mental Illness
WASHINGTON, D.C., April 24, 2026 The U.S. Food and Drug Administration has announced a series of accelerated regulatory actions...
Dogwood Secures FDA IND Nod for SP16 Pain Therapy
Alpharetta, Georgia, U.S. | April 15, 2026 Dogwood Therapeutics has announced a major regulatory milestone with the U.S. Food...
Advertisement
